Uncover key drivers, emerging technologies, and competitive movements shaping the noise, vibration, and harness (nvh) materials market from 2026–2035 with trusted insights from The Business Research Company

By how much is the Biotechnology Instruments Market expected to grow between 2026 and 2030?

The biotechnology instruments market has experienced substantial growth in recent years. Its expansion is projected from $80.9 billion in 2025 to reach $86.43 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 6.8%. The historical growth in this market can be attributed to factors such as limited automation in biotechnology laboratories, a reliance on manual sample processing, the expansion of pharmaceutical and biotech research, the adoption of conventional diagnostic instruments, and an increasing demand for laboratory consumables.

The biotechnology instruments market size is expected to undergo substantial expansion in the upcoming years. It is projected to achieve a valuation of $111.27 billion by 2030, advancing at a compound annual growth rate (CAGR) of 6.5%. This growth throughout the forecast period can be attributed to factors such as the development of advanced lab automation instruments, the integration of AI and robotics into research workflows, the expansion of genomics and proteomics studies, rising investment in pharmaceutical R&D, and the adoption of cloud-based data management solutions. Key trends identified for the forecast period include an increasing embrace of lab automation instruments, a growing demand for high-throughput screening and analysis, the continued expansion of proteomics and genomics research, increased utilization of IVD instruments in clinical diagnostics, and an enhanced focus on quality control and regulatory compliance.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19338&type=smp

Which Drivers Are Influencing Market Acceleration In The Biotechnology Instruments Market?

The expanding presence of chronic ailments is anticipated to fuel the expansion of the biotechnology instruments market moving ahead. These enduring health challenges, also referred to as chronic conditions or illnesses, are characterized by their prolonged duration, generally extending beyond three months. Their widespread occurrence stems from factors such as poor lifestyle choices, an aging demographic, and improved detection and diagnostic capabilities. Biotechnology instruments contribute to elevating the quality of life for individuals suffering from chronic diseases by refining diagnostic precision, optimizing therapeutic approaches, and facilitating superior disease management. Furthermore, these instruments aid in pinpointing potential drug candidates and comprehending their impact on chronic conditions. A notable example surfaced in June 2024, when the National Health Service, a UK-based government department, reported that 3,615,330 individuals registered with a general practitioner (GP) were diagnosed with non-diabetic hyperglycemia or pre-diabetes (a state of elevated blood sugar not yet reaching diabetic levels) in 2023. This represented an 18% surge from 3,065,825 cases recorded in 2022. Consequently, the escalating challenge posed by chronic diseases is stimulating growth in the biotechnology instruments market.

What Leading Segments Are Studied In The Biotechnology Instruments Market?

The biotechnology instruments market covered in this report is segmented –

1) By Product: Lab Automation Instruments, Life Science Consumables, In Vitro Diagnostic (IVD) Instruments

2) By Application: Clinical Diagnostics, Drug Discovery And Development, Proteomics And genomics, Cell Analysis, Other Applications

3) By End-user: Pharmaceutical And Biotechnology Companies, Hospitals And Diagnostic Laboratories, Academic And Research Institutes, Other End Users

Subsegments:

1) By Lab Automation Instruments: Robotic Liquid Handlers, Automated Plate Readers, Automated Workstations, Lab Sample Storage Systems

2) By Life Science Consumables: Reagents And Chemicals, Sample Collection And Transport Devices, Laboratory Plasticware, Culture Media And Kits

3) By In Vitro Diagnostic (IVD) Instruments: Molecular Diagnostic Instruments, Clinical Chemistry Analyzers, Hematology Analyzers, Immunoassay Analyzers

Which Trends Are Expected To Influence The Biotechnology Instruments Market In The Upcoming Years?

Major companies operating in the biotechnology instruments market are prioritizing the creation of innovative products, such as single-cell multi-omics offerings, to bolster personalized medicine approaches and advance studies in genomics, proteomics, and metabolomics. Single-cell multi-omics products are sophisticated technologies designed to analyze multiple types of biological information derived from individual cells. These products integrate data from various omics levels, including genomics, transcriptomics, proteomics, and metabolomics. For instance, in June 2023, Singleron Biotechnologies, a Germany-based biotechnology company, introduced two new instruments, the NEO and the Python Junior, with the aim of enhancing the standardization of single-cell analysis workflows. The Neo system is capable of processing up to half a million cells in a single run across four independent channels, thereby enabling high throughput and flexibility in handling different applications simultaneously. The Python Junior instrument is focused on dissociating solid tissues into high-quality single-cell suspensions. It achieves this by combining mechanical treatment with enzymatic digestion, which improves the efficiency of the dissociation process.

Which Major Industry Participants Are Leading The Biotechnology Instruments Market Growth?

Major companies operating in the biotechnology instruments market are Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Merck KGaA, Quest Diagnostics Inc., Avantor Inc., Agilent Technologies, Illumina Inc., Sartorius AG, Mettler Toledo, Perkin Elmer Inc., Shimadzu Corporation, Bruker Corporation, Zeiss Group, QIAGEN N.V., Novanta Inc., Cynosure LLC, Bio-Rad Laboratories Inc, Ori Biotech Limited, Hudson Robotics

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/biotechnology-instruments-global-market-report

Which Region Is Expected To Experience The Fastest Growth In The Biotechnology Instruments Market?

North America was the largest region in the biotechnology instruments market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biotechnology instruments market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Biotechnology Instruments Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=19338&type=smp

Browse Through More Reports Similar to the Global Biotechnology Instruments Market 2026, By The Business Research Company

Biotechnology Reagents Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/biotechnology-reagents-global-market-report

Animal Biotechnology Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/animal-biotechnology-global-market-report

White Biotechnology Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/white-biotechnology-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company